Laxygal (Drops) Instructions for Use
Marketing Authorization Holder
Teva Pharmaceutical Industries, Ltd. (Israel)
Manufactured By
Teva Czech Industries, s.r.o. (Czech Republic)
ATC Code
A06AB08 (Sodium picosulfate)
Active Substance
Sodium picosulfate (Rec.INN registered by WHO)
Dosage Form
| Laxygal | Oral drops 7.5 mg/1 ml: 10 ml or 25 ml dropper bottle |
Dosage Form, Packaging, and Composition
Oral drops in the form of a clear liquid from colorless to pale yellow-brown.
| 1 ml | 1 bottle | |
| Sodium picosulfate | 7.5 mg | 75 mg |
Excipients: sorbitol solution 70% (non-crystallizing), sodium ethylparahydroxybenzoate, hydrochloric acid 35%, purified water.
10 ml – dark glass dropper bottle (1) – cardboard boxes.
25 ml – dark glass dropper bottle (1) – cardboard boxes.
Clinical-Pharmacological Group
Laxative drug that stimulates intestinal peristalsis
Pharmacotherapeutic Group
Laxative
Pharmacological Action
Laxative. The active form of the drug, formed by hydrolysis under the influence of intestinal microorganisms, directly stimulates the nerve structures of the intestinal wall, resulting in accelerated movement of intestinal contents and reduced absorption of electrolytes and water.
The effect occurs 10-12 hours after administration.
Pharmacokinetics
After oral administration, it is not absorbed from the gastrointestinal tract and does not undergo enterohepatic circulation.
Indications
- Atonic constipation;
- Regulation of bowel movements (hemorrhoids, proctitis, anal fissures);
- Preparation for surgical operations, instrumental and radiological examinations.
ICD codes
| ICD-10 code | Indication |
| K59.0 | Constipation |
| K60 | Fissure and fistula of anus and rectum |
| K62.8 | Other specified diseases of anus and rectum (including proctitis) |
| K64 | Hemorrhoids and perianal venous thrombosis |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| ICD-11 code | Indication |
| DB32.1 | Slow-transit constipation |
| DB50.Z | Fissure or fistula of anal region, unspecified |
| DB6Z | Hemorrhoids or perianal venous diseases, unspecified |
| DB70.Z | Infections of anal and rectal regions, unspecified |
| DB72.Z | Some specified diseases of the anal canal, unspecified |
| DD91.1 | Functional constipation |
| DE2Z | Diseases of the digestive system, unspecified |
| EG61 | Infections of the anus or perianal skin |
| QB9A | Preparatory procedures for subsequent treatment |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally with a small amount of water, before bedtime.
For adults and children over 10 years, the initial dose is 12 to 24 drops.
For children aged 4 to 10 years, the initial dose is 6 to 12 drops.
Adjust the subsequent dose based on individual response and clinical effect.
Do not exceed the maximum recommended daily dose.
For preparation for surgical operations or examinations, follow the specific regimen prescribed by the physician.
Use the provided dropper for accurate dose measurement.
Do not use for more than 10 consecutive days without medical supervision.
Discontinue use if severe abdominal pain, diarrhea, or signs of dehydration occur.
Adverse Reactions
Possible diarrhea, abdominal pain, dehydration, disturbances of water-electrolyte balance, weakness, cramps, decreased blood pressure.
Contraindications
- Intestinal obstruction;
- Incarcerated hernia;
- Acute inflammatory diseases of the abdominal organs;
- Peritonitis;
- Abdominal pain (of unclear origin);
- Gastrointestinal bleeding;
- Metrorrhagia;
- Cystitis;
- Severe dehydration;
- Spastic constipation;
- Childhood (under 4 years);
- Pregnancy (first trimester);
- Hypersensitivity.
With caution – lactation period.
Use in Pregnancy and Lactation
During pregnancy, it should be used only as prescribed by a doctor. Contraindication: pregnancy (first trimester).
With caution – lactation period.
Pediatric Use
Contraindication: childhood (under 4 years). In children aged 4 to 10 years, dose adjustment is required (see Dosage Regimen).
Special Precautions
Should not be used daily without medical supervision for more than 10 days.
Children should use it only as prescribed by a doctor.
Overdose
Symptoms: see section “Adverse Reactions”. In addition, with chronic overdose, the development of ischemia of the colon mucosa, secondary hyperaldosteronism, urolithiasis, and renal tubular damage is possible.
Treatment: gastric lavage, correction of water-electrolyte balance disorders, antispasmodics.
Drug Interactions
Increased sensitivity to cardiac glycosides is possible.
Corticosteroids and diuretics increase the risk of electrolyte disturbances.
Broad-spectrum antibiotics reduce the laxative effect.
Storage Conditions
Store at a temperature from 10°C (50°F) to 25°C (77°F), in a place protected from light and out of reach of children.
Shelf Life
Shelf life – 3 years.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer